This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Jan 22;51(3):261-3.

doi: 10.1016/j.jacc.2007.07.090.

Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel

Paul A Gurbel, Wei C Lau, Udaya S Tantry

PMID: 18206733
DOI: 10.1016/j.jacc.2007.07.090

Free article

Editorial

Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel

Paul A Gurbel et al. J Am Coll Cardiol. 2008.

Free article

. 2008 Jan 22;51(3):261-3.

doi: 10.1016/j.jacc.2007.07.090.

Authors

Paul A Gurbel, Wei C Lau, Udaya S Tantry

PMID: 18206733
DOI: 10.1016/j.jacc.2007.07.090

No abstract available

PubMed Disclaimer

Comment on

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J. Gilard M, et al. J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064. J Am Coll Cardiol. 2008. PMID: 18206732 Clinical Trial.

Similar articles

PPI interactions with clopidogrel revisited.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Feb 23;51(1306):13-4. Med Lett Drugs Ther. 2009. PMID: 19229161
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J. Gilard M, et al. J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064. J Am Coll Cardiol. 2008. PMID: 18206732 Clinical Trial.
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin.
Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J. Gilard M, et al. J Thromb Haemost. 2006 Nov;4(11):2508-9. doi: 10.1111/j.1538-7836.2006.02162.x. Epub 2006 Aug 8. J Thromb Haemost. 2006. PMID: 16898956 No abstract available.
Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M, Tafreshi J, Pai RG. Tran M, et al. J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):326-37. doi: 10.1177/1074248410369109. Epub 2010 Oct 11. J Cardiovasc Pharmacol Ther. 2010. PMID: 20938037 Review.
[Dilemma between gastroprotection and cardiovascular prevention].
Venerito M, Kandulski A, Malfertheiner P. Venerito M, et al. Dtsch Med Wochenschr. 2010 Nov;135(44):2193-8. doi: 10.1055/s-0030-1267498. Epub 2010 Oct 26. Dtsch Med Wochenschr. 2010. PMID: 20979006 Review. German.

See all similar articles

Cited by

Effects of treatment with clopidogrel with or without proton pump inhibitor omeprazole on the risk of ischemic stroke: a nationwide cohort study.
Chang CC, Chou YC, Chang JY, Sun CA. Chang CC, et al. Sci Rep. 2024 Jan 19;14(1):1686. doi: 10.1038/s41598-024-51682-8. Sci Rep. 2024. PMID: 38242975 Free PMC article.
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.
Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ. Hillegass WB, et al. Vasc Health Risk Manag. 2011;7:445-59. doi: 10.2147/VHRM.S4746. Epub 2011 Jul 18. Vasc Health Risk Manag. 2011. PMID: 21822392 Free PMC article. Review.
Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW, Wen YW, Huang WF, Chen PF, Kuo KN, Hsiao FY. Tsai YW, et al. J Gastroenterol. 2011 Jan;46(1):39-45. doi: 10.1007/s00535-010-0299-0. Epub 2010 Sep 2. J Gastroenterol. 2011. PMID: 20811753
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM. Ray WA, et al. Ann Intern Med. 2010 Mar 16;152(6):337-45. doi: 10.7326/0003-4819-152-6-201003160-00003. Ann Intern Med. 2010. PMID: 20231564 Free PMC article.
Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?
Srinivas NR. Srinivas NR. Eur J Drug Metab Pharmacokinet. 2009 Jul-Sep;34(3-4):147-50. doi: 10.1007/BF03191165. Eur J Drug Metab Pharmacokinet. 2009. PMID: 20166430

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information